Metformin Hydrochloride Wave Pharma (Metformin Hydrochloride)

Metformin Hydrochloride is a biguanide antidiabetic that acts on glucose metabolism in type 2 diabetes and related conditions.

• Type 2 diabetes mellitus: improves glycemic control and reduces HbA1c levels.
• Prediabetes (impaired glucose tolerance): lowers the risk of progression to overt diabetes.
• Polycystic ovary syndrome: helps reduce insulin resistance and may improve menstrual regularity.

• Metformin Hydrochloride reduces hepatic gluconeogenesis, decreases intestinal glucose absorption, and increases peripheral glucose uptake by enhancing insulin sensitivity. It activates AMP‑activated protein kinase (AMPK), which modulates metabolic pathways involved in glucose and lipid homeostasis, leading to lower blood glucose concentrations without stimulating insulin secretion.

Metformin Hydrochloride may cause a range of adverse reactions, from mild gastrointestinal discomfort to rare but serious metabolic disturbances.

Common Side Effects

• Nausea: mild to moderate upset stomach.
• Diarrhea: frequent loose stools.
• Abdominal discomfort: cramping or bloating.
• Metallic taste: transient alteration of taste perception.
• Decreased appetite: reduced desire to eat.
• Vitamin B12 deficiency: long‑term use may lower B12 levels.

Serious or Rare Side Effects

• Lactic acidosis: a rare but life‑threatening buildup of lactate.
• Severe skin reactions: such as Stevens‑Johnson syndrome.
• Hepatic dysfunction: abnormal liver enzymes or hepatitis.
• Pancreatitis: inflammation of the pancreas.
• Hypoglycemia: usually when combined with other glucose‑lowering agents.

Metformin Hydrochloride requires careful monitoring and specific safety measures before and during therapy.

• Renal function assessment: evaluate creatinine clearance before initiation and periodically thereafter.
• Hepatic function monitoring: check liver enzymes to reduce risk of lactic acidosis.
• Lactic acidosis risk: avoid in patients with conditions predisposing to hypoxia or severe infection.
• Pregnancy and lactation: use only if clearly needed after risk‑benefit evaluation.
• Vitamin B12 monitoring: assess levels during long‑term therapy.
• Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Metformin Hydrochloride can interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

• Iodinated contrast agents: may precipitate acute renal failure and increase lactic acidosis risk.
• Cimetidine: can raise metformin plasma concentrations.
• Alcohol excess: enhances risk of lactic acidosis.

Moderate Interactions (Monitor Closely)

• Beta‑blockers: may mask hypoglycemia symptoms.
• Diuretics: can affect renal clearance of metformin.
• ACE inhibitors/ARBs: monitor renal function and potassium levels.
• Warfarin: may require INR monitoring as metformin can affect anticoagulation control.